Cargando…

A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587]

BACKGROUND: The WHO recommends that adults with uncomplicated P. falciparum successfully treated with a blood schizonticide receive a single dose of primaquine (PQ) 45 mg as a gametocytocidal agent. An earlier pilot study suggested that 75 mg of bulaquine (BQ), of which PQ is a major metabolite, may...

Descripción completa

Detalles Bibliográficos
Autores principales: Gogtay, NJ, Kamtekar, KD, Dalvi, SS, Mehta, SS, Chogle, AR, Aigal, U, Kshirsagar, NA
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1389708/
https://www.ncbi.nlm.nih.gov/pubmed/16448575
http://dx.doi.org/10.1186/1471-2334-6-16
_version_ 1782126910975770624
author Gogtay, NJ
Kamtekar, KD
Dalvi, SS
Mehta, SS
Chogle, AR
Aigal, U
Kshirsagar, NA
author_facet Gogtay, NJ
Kamtekar, KD
Dalvi, SS
Mehta, SS
Chogle, AR
Aigal, U
Kshirsagar, NA
author_sort Gogtay, NJ
collection PubMed
description BACKGROUND: The WHO recommends that adults with uncomplicated P. falciparum successfully treated with a blood schizonticide receive a single dose of primaquine (PQ) 45 mg as a gametocytocidal agent. An earlier pilot study suggested that 75 mg of bulaquine (BQ), of which PQ is a major metabolite, may be a useful alternate to PQ. METHODS: In a randomized, partial blind study, 90 hospitalized adults with Plasmodium falciparum malaria that was blood schizonticide-responsive and a gametocytemia of > 55/μl within 3 days of diagnosis were randomized to receive single doses of either PQ 45 mg or BQ 75 mg on day 4. We assessed gametocytemia on days 8, 15, 22 and 29 and gametocyte viability as determined by exflagellation (2° end point) on day 8. RESULTS: On day 8, 20/31 (65%) primaquine recipients versus 19/59 (32%) bulaquine recipients showed persistence of gametocytes (P = 0.002). At day 15 and beyond, all patients were gametocyte free. On day 8, 16/31 PQ and 7/59 BQ volunteers showed gametocyte viability (p = 0.000065). CONCLUSION: BQ is a safe, useful alternate to PQ as a Plasmodium falciparum gametocytocidal agent and may clear gametocytemia faster than PQ.
format Text
id pubmed-1389708
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-13897082006-03-07 A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587] Gogtay, NJ Kamtekar, KD Dalvi, SS Mehta, SS Chogle, AR Aigal, U Kshirsagar, NA BMC Infect Dis Research Article BACKGROUND: The WHO recommends that adults with uncomplicated P. falciparum successfully treated with a blood schizonticide receive a single dose of primaquine (PQ) 45 mg as a gametocytocidal agent. An earlier pilot study suggested that 75 mg of bulaquine (BQ), of which PQ is a major metabolite, may be a useful alternate to PQ. METHODS: In a randomized, partial blind study, 90 hospitalized adults with Plasmodium falciparum malaria that was blood schizonticide-responsive and a gametocytemia of > 55/μl within 3 days of diagnosis were randomized to receive single doses of either PQ 45 mg or BQ 75 mg on day 4. We assessed gametocytemia on days 8, 15, 22 and 29 and gametocyte viability as determined by exflagellation (2° end point) on day 8. RESULTS: On day 8, 20/31 (65%) primaquine recipients versus 19/59 (32%) bulaquine recipients showed persistence of gametocytes (P = 0.002). At day 15 and beyond, all patients were gametocyte free. On day 8, 16/31 PQ and 7/59 BQ volunteers showed gametocyte viability (p = 0.000065). CONCLUSION: BQ is a safe, useful alternate to PQ as a Plasmodium falciparum gametocytocidal agent and may clear gametocytemia faster than PQ. BioMed Central 2006-02-01 /pmc/articles/PMC1389708/ /pubmed/16448575 http://dx.doi.org/10.1186/1471-2334-6-16 Text en Copyright © 2006 Gogtay et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gogtay, NJ
Kamtekar, KD
Dalvi, SS
Mehta, SS
Chogle, AR
Aigal, U
Kshirsagar, NA
A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587]
title A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587]
title_full A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587]
title_fullStr A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587]
title_full_unstemmed A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587]
title_short A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587]
title_sort randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [iscrtn50134587]
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1389708/
https://www.ncbi.nlm.nih.gov/pubmed/16448575
http://dx.doi.org/10.1186/1471-2334-6-16
work_keys_str_mv AT gogtaynj arandomizedparallelstudyofthesafetyandefficacyof45mgprimaquineversus75mgbulaquineasgametocytocidalagentsinadultswithbloodschizonticideresponsiveuncomplicatedfalciparummalariaiscrtn50134587
AT kamtekarkd arandomizedparallelstudyofthesafetyandefficacyof45mgprimaquineversus75mgbulaquineasgametocytocidalagentsinadultswithbloodschizonticideresponsiveuncomplicatedfalciparummalariaiscrtn50134587
AT dalviss arandomizedparallelstudyofthesafetyandefficacyof45mgprimaquineversus75mgbulaquineasgametocytocidalagentsinadultswithbloodschizonticideresponsiveuncomplicatedfalciparummalariaiscrtn50134587
AT mehtass arandomizedparallelstudyofthesafetyandefficacyof45mgprimaquineversus75mgbulaquineasgametocytocidalagentsinadultswithbloodschizonticideresponsiveuncomplicatedfalciparummalariaiscrtn50134587
AT choglear arandomizedparallelstudyofthesafetyandefficacyof45mgprimaquineversus75mgbulaquineasgametocytocidalagentsinadultswithbloodschizonticideresponsiveuncomplicatedfalciparummalariaiscrtn50134587
AT aigalu arandomizedparallelstudyofthesafetyandefficacyof45mgprimaquineversus75mgbulaquineasgametocytocidalagentsinadultswithbloodschizonticideresponsiveuncomplicatedfalciparummalariaiscrtn50134587
AT kshirsagarna arandomizedparallelstudyofthesafetyandefficacyof45mgprimaquineversus75mgbulaquineasgametocytocidalagentsinadultswithbloodschizonticideresponsiveuncomplicatedfalciparummalariaiscrtn50134587
AT gogtaynj randomizedparallelstudyofthesafetyandefficacyof45mgprimaquineversus75mgbulaquineasgametocytocidalagentsinadultswithbloodschizonticideresponsiveuncomplicatedfalciparummalariaiscrtn50134587
AT kamtekarkd randomizedparallelstudyofthesafetyandefficacyof45mgprimaquineversus75mgbulaquineasgametocytocidalagentsinadultswithbloodschizonticideresponsiveuncomplicatedfalciparummalariaiscrtn50134587
AT dalviss randomizedparallelstudyofthesafetyandefficacyof45mgprimaquineversus75mgbulaquineasgametocytocidalagentsinadultswithbloodschizonticideresponsiveuncomplicatedfalciparummalariaiscrtn50134587
AT mehtass randomizedparallelstudyofthesafetyandefficacyof45mgprimaquineversus75mgbulaquineasgametocytocidalagentsinadultswithbloodschizonticideresponsiveuncomplicatedfalciparummalariaiscrtn50134587
AT choglear randomizedparallelstudyofthesafetyandefficacyof45mgprimaquineversus75mgbulaquineasgametocytocidalagentsinadultswithbloodschizonticideresponsiveuncomplicatedfalciparummalariaiscrtn50134587
AT aigalu randomizedparallelstudyofthesafetyandefficacyof45mgprimaquineversus75mgbulaquineasgametocytocidalagentsinadultswithbloodschizonticideresponsiveuncomplicatedfalciparummalariaiscrtn50134587
AT kshirsagarna randomizedparallelstudyofthesafetyandefficacyof45mgprimaquineversus75mgbulaquineasgametocytocidalagentsinadultswithbloodschizonticideresponsiveuncomplicatedfalciparummalariaiscrtn50134587